Papers: 10.1038/s41375-020-0891-0

https://doi.org/10.1038/s41375-020-0891-0

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation

Cited by: 181
Author(s): F La Rosée, H Bremer, Iris Gehrke, A Kehr, Andreas Hochhaus, Sebastian Birndt, M. Fellhauer, Martin Henkes, Bernhard Kumle, Salvatore Russo, Paul La Rosée
Published: over 6 years ago

Software Mentions 1